Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria

Journal of Urology

Volumn 166, Issue 1, 2001, Pages 275-280

  Toblli, Jorge Eduardo ^a   Ferder, León ^a   Stella, Inés ^a   Angerosa, Margarita ^a   Inserra, Felipe ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Enalapril; Hyperoxaluria; Kidney; Peptidyl dipeptidase A; Rats; Sprague Dawley

Indexed keywords

ALBUMIN; ALPHA ACTIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; ETHYLENE GLYCOL; MONOCLONAL ANTIBODY; OXALIC ACID; PROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; HYPEROXALURIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCORING SYSTEM; URINARY EXCRETION;

EID: 0034968025     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66144-7     Document Type: Article

References (34)

1. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria
2. Possible pathogenesis of renal fibrosis
3. Tubulointerstitial changes as a major determinant in the progression of renal damage
4. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix
5. TGF-beta: Regulation of extracellular matrix
6. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: Evidence for a role for insulin-like growth factor I
7. Paracrine stimulation of human renal fibroblasts by proximal tubule cells
8. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril
9. Enalapril reduces collagen type IV synthesis and expansion of interstitium in the obstructed rat kidney
10. Renal interstitial sclerosis in aging: Effects of enalapril and nifedipine
11. Urate and uric acid nephropathy, cystinosis, and oxalosis
12. Enalapril prevents tubulointerstitial lesions by hyperoxaluria
13. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
14. Distribution of renin mRNA and its protein in the developing kidney
15. Understanding the nature of renal disease progression
16. The progression of renal disease
17. Angiotensin actions in the kidney: Renewed insight into the old hormone
18. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis
19. Enalapril (E) improves urine albumin excretion (UAE) in rats with tubulointerstitial lesions by hyperoxaluria
20. Monocyte/macrophage (Mo/Ma) infiltration in the renal interstitium of hyperoxaluric (Hox) rats treated with enalapril (E) and losartan (L)
21. Transforming growth factor-β1 (TGF-β1) and collagen type III (COL III) in hyperoxaluric (Hox) rats treated with enalapril
22. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
23. The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions
24. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis
25. Preventive effect of ACE inhibition on interstitial myofibroblast formation and matrix deposition in a nephrotic model
26. Calcium oxalate nephrolithiasis: Effect of renal crystal deposition on the cellular composition of the renal interstitium
27. Oxalate toxicity in LLC-PK1 cells: Role of free radicals
28. Molecular Insight into renal interstitial fibrosis
29. Oxidative damage and fibrogenesis
30. Enalapril and captopril enhance antioxidant defenses in mouse tissue
31. Protective effect of high doses of losartan on tubulointerstitial lesions in hyperoxaluric rats
32. Enalapril enhances antioxidant defenses in renal tissue in rats with hyperoxaluria
33. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues
34. Epidemiology of primary hyperoxaluria type I. Socíetê de Néphrologie and the Socíetê de Néphrologie Pédiatrique